<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Stefanik M</submitter><funding>Ministry of Education Youth and Sports</funding><pagination>354</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8874615</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(2)</volume><pubmed_abstract>Diphyllin is a natural arylnaphtalide lignan extracted from tropical plants of particular importance in traditional Chinese medicine. This compound has been described as a potent inhibitor of vacuolar (H+)ATPases and hence of the endosomal acidification process that is required by numerous enveloped viruses to trigger their respective viral infection cascades after entering host cells by receptor-mediated endocytosis. Accordingly, we report here a revised, updated, and improved synthesis of diphyllin, and demonstrate its antiviral activities against a panel of enveloped viruses from Flaviviridae, Phenuiviridae, Rhabdoviridae, and Herpesviridae families. Diphyllin is not cytotoxic for Vero and BHK-21 cells up to 100 µM and exerts a sub-micromolar or low-micromolar antiviral activity against tick-borne encephalitis virus, West Nile virus, Zika virus, Rift Valley fever virus, rabies virus, and herpes-simplex virus type 1. Our study shows that diphyllin is a broad-spectrum host cell-targeting antiviral agent that blocks the replication of multiple phylogenetically unrelated enveloped RNA and DNA viruses. In support of this, we also demonstrate that diphyllin is more than just a vacuolar (H+)ATPase inhibitor but may employ other antiviral mechanisms of action to inhibit the replication cycles of those viruses that do not enter host cells by endocytosis followed by low pH-dependent membrane fusion.</pubmed_abstract><journal>Viruses</journal><pubmed_title>Diphyllin Shows a Broad-Spectrum Antiviral Activity against Multiple Medically Important Enveloped RNA and DNA Viruses.</pubmed_title><pmcid>PMC8874615</pmcid><funding_grant_id>CZ.02.1.01/0.0/0.0/15 003/0000495</funding_grant_id><funding_grant_id>LTAUSA18016</funding_grant_id><pubmed_authors>Fojtikova M</pubmed_authors><pubmed_authors>Haviernik J</pubmed_authors><pubmed_authors>Sedlak M</pubmed_authors><pubmed_authors>Dufkova L</pubmed_authors><pubmed_authors>Bartacek J</pubmed_authors><pubmed_authors>Ruzek D</pubmed_authors><pubmed_authors>Bhosale DS</pubmed_authors><pubmed_authors>Salat J</pubmed_authors><pubmed_authors>Strakova P</pubmed_authors><pubmed_authors>Svoboda J</pubmed_authors><pubmed_authors>Stefanik M</pubmed_authors><pubmed_authors>Huvarova I</pubmed_authors><pubmed_authors>Miller AD</pubmed_authors><pubmed_authors>Eyer L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Diphyllin Shows a Broad-Spectrum Antiviral Activity against Multiple Medically Important Enveloped RNA and DNA Viruses.</name><description>Diphyllin is a natural arylnaphtalide lignan extracted from tropical plants of particular importance in traditional Chinese medicine. This compound has been described as a potent inhibitor of vacuolar (H+)ATPases and hence of the endosomal acidification process that is required by numerous enveloped viruses to trigger their respective viral infection cascades after entering host cells by receptor-mediated endocytosis. Accordingly, we report here a revised, updated, and improved synthesis of diphyllin, and demonstrate its antiviral activities against a panel of enveloped viruses from Flaviviridae, Phenuiviridae, Rhabdoviridae, and Herpesviridae families. Diphyllin is not cytotoxic for Vero and BHK-21 cells up to 100 µM and exerts a sub-micromolar or low-micromolar antiviral activity against tick-borne encephalitis virus, West Nile virus, Zika virus, Rift Valley fever virus, rabies virus, and herpes-simplex virus type 1. Our study shows that diphyllin is a broad-spectrum host cell-targeting antiviral agent that blocks the replication of multiple phylogenetically unrelated enveloped RNA and DNA viruses. In support of this, we also demonstrate that diphyllin is more than just a vacuolar (H+)ATPase inhibitor but may employ other antiviral mechanisms of action to inhibit the replication cycles of those viruses that do not enter host cells by endocytosis followed by low pH-dependent membrane fusion.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2024-11-09T11:56:19.055Z</modification><creation>2024-11-09T11:56:19.055Z</creation></dates><accession>S-EPMC8874615</accession><cross_references><pubmed>35215947</pubmed><doi>10.3390/v14020354</doi></cross_references></HashMap>